Rappta Therapeutics Competitors and Similar CompaniesClear all
Rappta Therapeutics's competitors and similar companies include Infinity Pharmaceuticals, Exelixis, TRACON Pharmaceuticals and Iovance Biotherapeutics.
 Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. |  TRACON Pharmaceuticals TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. |  Iovance Biotherapeutics Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes. | |||
Founding Date | Founding Date 2006 | Founding Date 2000 | Founding Date 1994 | Founding Date 2006 | Founding Date 2013 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Helsinki, FI HQ | Locations Cambridge, US HQ | Locations Alameda, US HQ | Locations San Diego, US HQ | Locations San Carlos, US HQ New York, US Philadelphia, US Philadelphia, US Tampa, US |
Employees | Employees 8 | Employees 25 | Employees 1,14712% decrease | Employees 268% increase | Employees 14868% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 726.1 k | Valuation ($) 8.2 b | Valuation ($) 279.4 k | Valuation ($) 3.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $12m (FY, 2023) | Revenue (est.) $263.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $83.7m (FY, 2025) | Cost of goods N/A | Cost of goods $173.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $2.2b (FY, 2025) | Gross profit N/A | Gross profit $90.3m (FY, 2025) |
Net income | Net income N/A | Net income ($44.4m) (FY, 2022) | Net income $782.6m (FY, 2025) | Net income ($3.6m) (FY, 2023) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 10.6m | Total funding raised $ 106.6m | Total funding raised N/A | Total funding raised $ 41m | Total funding raised $ 100m |
For sources of this data, please see the company profile
View Company Profiles
Infinity Pharmaceuticals
HQ
Cambridge, US
Employees
25
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
View company
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyTRACON Pharmaceuticals
HQ
San Diego, US
Employees
26↑ 8% increase
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration.
View companyIovance Biotherapeutics
HQ
San Carlos, US
Employees
148
Iovance Biotherapeutics (formerly Lion Biotechnologies) is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes.
View company